Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds

• Status: Recruiting
• Trial end date: 2022-03-15
• Target enrollment: 0
• Participant gender: All

Summary

Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ClinAmygate
• Collaborators: Al Safwa Hospital; Al Zohour Hospital; Al-Menia Univeristy Hospital; Misr University for Science and Technology; MSKMC Univeristy Hospital
• Treatments: Anti-Bacterial Agents; Triclosan

Criteria

Inclusion Criteria:

• age: 18-75

• clean-contaminated wound surgery

Exclusion Criteria:

• Patient has immunodeficiency disorder.

• Patient receiving anti-cancer / immunosuppressive therapy.

• Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.